GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals AstraZeneca AZN and Boehringer ...
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...
March 18 (Reuters) - Drugmaker AstraZeneca (AZN.L), opens new tab said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, ...
WAUWATOSA, Wis. (CBS 58) -- A second major producer of inhalers announced Monday it will cap out-of-pocket costs at $35. AstraZeneca joined Boehringer Ingelheim in pledging to limit patients' costs to ...
PLATTSBURGH, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Monaghan Medical is proud to announce the AeroChamber2Go ® Valved Holding Chamber (VHC) is now available at 4,400 Walmart Pharmacy locations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results